{"prompt": "['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'This study is designed to enroll breast and GI cancer patients who are currently receiving or', 'recently completed active neurotoxic chemotherapy and have clinically documented grade 1 or', '2 neuropathy by CTCAE v5.0 criteria.', '3.1', 'Inclusion Criteria', 'Breast or GI cancer stage I-III', 'Currently receiving or recently completed neurotoxic chemotherapy (either adjuvant or', 'neoadjuvant). Currently is defined as including up until when the next cycle would be', 'delivered, that is if the patient is getting chemotherapy every week, this would include a', 'week after their last treatment; if the patient is getting treatment every 2 weeks, this', 'would include 2 weeks after their last treatment; if the patient is getting treatment every', '3 weeks, this would include 3 weeks after their last treatment, etc. Recently completed', 'is defined as 6 weeks after this time period. For example, if a patient was getting', 'chemotherapy every week, this would include seven weeks after their last treatment; if', 'the patient was getting treatment every 2 weeks, this would include 8 weeks after their', 'last treatment; if the patient were getting treatment every 3 weeks, this would include 9', 'weeks after their last treatment, etc.', 'Clinical symptoms of peripheral neuropathy of grade 1 or grade 2 as measured by the', 'NCI-CTCAE.', 'Ability and willingness to understand and sign an informed consent.', '3.2', 'Exclusion Criteria', 'Self-reported or documented history of UNRESOLVED pre-existing peripheral', 'neuropathy due to diabetes, HIV, or other conditions.', 'Unable to provide medical history.', 'Male patients.', 'Pregnant', 'Unwilling to receive acupuncture or unable to travel for treatments.', '3.3', 'Inclusion of women and minorities', '3.3.1 Patients of all races and ethnicity who meet the above-described eligibility criteria', 'are eligible for this trial.', 'Page 7 of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', '3.3.2 We aim to enroll at least 25% Black or African Americans (N=6). Because of the', 'low incidence of cancer among American Indian/Alaska Native, Asian, and', 'Hispanic/Latinos in our catchment area, we do not expect accruals of individuals', 'of those ancestries; however, no ancestry background is being excluded. Should', 'we not meet or exceed these estimates, the PI will engage the Cancer Center', 'Health Equity Advisory Group to discuss strategies to enhance recruitment in the', 'target populations.', '4.0 Methods', '4.1', 'Registration Procedures', 'All patients entered on any WFBCCC trial, whether treatment, companion, or cancer', 'control trial, must be linked to a study protocol in EPIC within 24 hours of Informed', 'Consent. Patients must be registered prior to the initiation of treatment.', 'You must perform the following steps in order to ensure prompt registration of your', 'patient:', '1. Complete the Eligibility Checklist (Appendix / A)', '2. Complete the Protocol Registration Form (Appendix B)', '3. Complete the Ethnicity Verification Form (Appendix C)', '4. Alert the Cancer Center registrar by phone, and then send the signed Informed', 'Consent Form, Eligibility Checklist and Protocol Registration Form to the registrar,', 'either by fax or e-mail.', '*Protocol Registration is open from 8:30 AM - 4:00 PM, Monday-Friday.', '5. Fax/e-mail ALL eligibility source documents with registration. Patients will not be', 'registered without all required supporting documents.', 'To complete the registration process, the Registrar will:', 'assign a patient study number', 'register the patient on the study', 'Page 8 of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', '4.2 Study Activities', 'Study Calendar*', 'Week 12', 'End of', 'Treatment', 'Baseline', 'Assessment', 'Peripheral', '30 Day', 'Intervention', '(10 +/2', 'Post', 'Nerve', 'Follow-up (+', '(weeks', 'weeks post', 'Treatment', 'Screening', 'Assessment', 'or - 5 days)', '2-12)', 'baseline)', 'review', 'Informed Consent', 'X', 'Randomization', 'X', 'Pregnancy Test for Women', 'of Childbearing Potential', 'X', 'Medical history', '(Appendix D)', 'X', 'Physician Rated CTCAE', '(Appendix M)', 'X', 'X', 'QLQ-CIPN20 (Appendix E)', 'X', 'X', 'PRO-CTAE (Appendix E E)', 'X', 'X', 'Abbreviated Neurological', 'Examination', 'X', 'X', 'Nerve Conduction Study', '(Appendix F)', 'X', 'X', 'Peripheral Nerve', 'Ultrasound', '(Appendix G)', 'X', 'X', 'Skin Biopsy (Appendix H)', 'X', 'X', 'Acupuncture Expectancy', 'Scale (Appendix P)', 'X', 'Follow-up Form for Skin', 'Biopsy (Appendix. J)g', 'X', 'X', 'Research Blood Drawd', 'X', 'X', 'Acupuncture treatments', '(Appendix 0)e', 'X', 'Post treatment review', 'X', 'X', 'Adverse Events', 'X', 'X', 'X', 'X', 'X', 'Chemotherapy Form', '(Appendix N)', 'X', 'Page 9 of 55']\n\n###\n\n", "completion": "END"}